G9426 HCPCS Level II code: Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
G9426 is the HCPCS code for “Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9426Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
Short description: Impr med time edarr pain med
HCPCS · United States
Medicare details
The indicators CMS publishes with G9426 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2015
Where G9426 sits
- 1G codesProcedures and professional services
- 2Active code G9426Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9426 mean?
G9426 is the HCPCS code for “Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9426?
CMS lists G9426’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9426
All G codesG9420Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancerG9421Primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow…G9422Primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and…G9423Documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign…G9424Specimen site other than anatomic location of lung, or classified as nsclc-nosG9425Primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma…G9427Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patientsG9428Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive…G9429Documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of…G9430Specimen site other than anatomic cutaneous locationG9431Pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for…G9432Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented